Carmen Espejo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Journal: Neurology

Published: August 20, 2026

"Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.

"Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: February 20, 2026

Bile acid scaffold engineering reveals an androstane-triol derivative as a potent immunomodulator with therapeutic efficacy in EAE.

Bile acid scaffold engineering reveals an androstane-triol derivative as a potent immunomodulator with therapeutic efficacy in EAE.

Journal: Journal of neuroinflammation

Published: December 22, 2025

Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage.

Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage.

Journal: International journal of molecular sciences

Published: September 19, 2025

Reprogramming autoimmunity: inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis.

Reprogramming autoimmunity: inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis.

Journal: Journal of neuroinflammation

Published: July 16, 2025

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 30, 2025

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 09, 2025

Age-Related Disability Outcomes After a First Demyelinating Event.

Age-Related Disability Outcomes After a First Demyelinating Event.

Journal: Neurology

Published: February 04, 2025

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 03, 2025

Multiple sclerosis: molecular pathogenesis and therapeutic intervention.

Multiple sclerosis: molecular pathogenesis and therapeutic intervention.

Journal: Signal transduction and targeted therapy

Published: December 19, 2024

Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 11, 2024

Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study.

Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 26, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026